Clinical Trials
3
Active:0
Completed:0
Trial Phases
1 Phases
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (100.0%)Evidence Amyloid Scan EEG Study
- Conditions
- Alzheimer DiseaseMild Cognitive ImpairmentDementia Frontal
- First Posted Date
- 2018-08-23
- Last Posted Date
- 2018-08-23
- Lead Sponsor
- Metabolic Therapy Inc.
- Target Recruit Count
- 2000
- Registration Number
- NCT03644043
- Locations
- 🇺🇸
Translational Cognitive Research, Houston, Texas, United States
Effects of Chromium on Insulin Resistance in Alzheimer Disease Patients
Not Applicable
- Conditions
- Alzheimer Disease
- First Posted Date
- 2017-01-31
- Last Posted Date
- 2017-01-31
- Lead Sponsor
- Metabolic Therapy Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT03038282
Magnesium Sulfate for the Improvement of Cognition in Patients With Alzheimer Disease
Not Applicable
- Conditions
- Alzheimer Disease
- First Posted Date
- 2017-01-31
- Last Posted Date
- 2017-01-31
- Lead Sponsor
- Metabolic Therapy Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT03038334
News
No news found